Dr. Reddy’s Laboratories Share Price Target 2024-2050: Long-term Forecast & Analysis
Dr. Reddy’s Laboratories is an Indian multinational pharmaceutical company listed on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
The global pharmaceutical market, including India, is expected to remain a key growth driver for the industry, driven by efforts to improve access to healthcare, rising per capita income, and expanding insurance coverage. Over the past two decades, India’s dominance in the global generics market has led to a tenfold increase in its pharmaceutical industry, now supplying around 40% of generics in the U.S. and meeting over 60% of the global vaccine demand.
Looking ahead, India is poised to be one of the fastest-growing pharmaceutical markets, with an expected CAGR of around 11%. The country has significant opportunities to move up the value chain beyond generics, with potential in specialty pharma, biosimilars, novel biological drugs, vaccines, and other areas of unmet medical need. These developments position India to establish itself as a global innovation hub in the pharmaceutical sector.
This detailed post will explore Dr. Reddy’s Laboratories’ share price targets from 2024 to 2050, utilizing various technical analysis approaches to provide long-term forecasts and predict future trends.
Overview of Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is a leading global pharmaceutical company that manufactures and markets a wide range of medications in India and internationally. With R&D centers, manufacturing facilities, and a commercial presence around the world, Dr. Reddy’s serves over half a billion patients globally. The company offers more than 190 drugs and 60 active pharmaceutical ingredients (APIs) for pharmaceutical manufacturing, biotechnology, critical care, and diagnostic kits.
| Company Name | Dr. Reddy’s Laboratories Limited |
| Industry | Pharmaceuticals |
| Founded | 1984 |
| Country | India |
| Official Website | www.drreddys.com |
On this page, you’ll find comprehensive information about the company’s current stock price, live charts, and the latest forecasts for both short- and long-term periods:
- Real-Time Stock Price: Updated every minute for the most current data.
- Technical Indicators: Updated according to specific time frames to provide timely insights.
- Financial Reports: Updated quarterly to reflect the latest financial performance.
- Stock Charts: Refreshed every minute for up-to-the-minute visual data.
Dr. Reddy’s Laboratories Stock Price Forecast for Tomorrow and the Coming Week Based on the Last 30 Days.
| Date | Min. Price | Max. Price | Stock Price |
|---|
Technical Analysis of Dr. Reddy’s Laboratories Based on Indicators
You can use indicator-based technical analysis for Dr. Reddy’s Laboratories Ltd. to identify better entry points in the market. Adjust the time frame to suit your needs for the best analysis.
Dr. Reddy’s Laboratories technical analysis signals are categorized to help you easily understand the market trends:
- “Sell” or “Strong Sell”: Indicates that most signals are bearish (negative).
- “Buy” or “Strong Buy”: Indicates that most signals are bullish (positive).
Keep in mind that signals can vary across different time frames. For short-term analysis, it’s recommended to use settings ranging from 15 minutes to 2 hours. If you’re planning to hold Dr. Reddy’s Laboratories Ltd. stock for more than a week, use settings that range from days to weeks.
Dr. Reddy’s Laboratories Ltd. Financials Data
Use the landscape mode for best viewing on mobile devices.
Dr. Reddy’s Laboratories Share Price Targets: 2024 to 2050 Snapshot
| Year | Minimum Price | Maximum Price |
|---|---|---|
| 2024 | ₹ 7,036 | ₹ 7,094 |
| 2025 | ₹ 7,011 | ₹ 7,501 |
| 2026 | ₹ 7,439 | ₹ 7,949 |
| 2027 | ₹ 7,867 | ₹ 8,378 |
| 2028 | ₹ 8,296 | ₹ 8,805 |
| 2029 | ₹ 8,723 | ₹ 9,682 |
| 2030 | ₹ 9,491 | ₹ 10,711 |
| 2040 | ₹ 26,012 | ₹ 31,037 |
| 2050 | ₹ 71,288 | ₹ 89,937 |
These “Dr. Reddy’s Laboratories Limited” price targets are for reference purposes only. Short-term and long-term Dr. Reddy’s Laboratories stock price predictions may vary due to the time series that were analyzed differently. This prediction assumes positive market sentiments, and this analysis does not cover any uncertainties in the company or global market conditions.
Dr. Reddy’s Laboratories Share Price Target 2024
| Months | Minimum Price | Maximum Price |
|---|---|---|
| October 2024 | ₹ 7,047 | ₹ 7,094 |
| November 2024 | ₹ 7,057 | ₹ 7,090 |
| December 2024 | ₹ 7,036 | ₹ 7,074 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2024 is estimated to be ₹7094.
● However, by the end of 2024, the price target is expected to decline, potentially reaching ₹7074 due to bearish market trends.
Dr. Reddy’s Laboratories Share Price Target 2025
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2025 | ₹ 7,041 | ₹ 7,092 |
| February 2025 | ₹ 7,041 | ₹ 7,072 |
| March 2025 | ₹ 7,011 | ₹ 7,074 |
| April 2025 | ₹ 7,084 | ₹ 7,221 |
| May 2025 | ₹ 7,124 | ₹ 7,198 |
| June 2025 | ₹ 7,178 | ₹ 7,318 |
| July 2025 | ₹ 7,332 | ₹ 7,408 |
| August 2025 | ₹ 7,356 | ₹ 7,407 |
| September 2025 | ₹ 7,346 | ₹ 7,484 |
| October 2025 | ₹ 7,475 | ₹ 7,520 |
| November 2025 | ₹ 7,484 | ₹ 7,520 |
| December 2025 | ₹ 7,465 | ₹ 7,501 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2025 is estimated to be ₹7092.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹7318.
● However, by the end of 2025, the price target is expected to reach ₹7501 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2026
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2026 | ₹ 7,470 | ₹ 7,521 |
| February 2026 | ₹ 7,473 | ₹ 7,500 |
| March 2026 | ₹ 7,439 | ₹ 7,504 |
| April 2026 | ₹ 7,505 | ₹ 7,646 |
| May 2026 | ₹ 7,554 | ₹ 7,625 |
| June 2026 | ₹ 7,601 | ₹ 7,748 |
| July 2026 | ₹ 7,752 | ₹ 7,836 |
| August 2026 | ₹ 7,782 | ₹ 7,835 |
| September 2026 | ₹ 7,773 | ₹ 7,910 |
| October 2026 | ₹ 7,902 | ₹ 7,946 |
| November 2026 | ₹ 7,912 | ₹ 7,949 |
| December 2026 | ₹ 7,894 | ₹ 7,929 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2026 is estimated to be ₹7521.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹7748.
● However, by the end of 2026, the price target is expected to reach ₹7929 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2027
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2027 | ₹ 7,899 | ₹ 7,949 |
| February 2027 | ₹ 7,899 | ₹ 7,927 |
| March 2027 | ₹ 7,867 | ₹ 7,925 |
| April 2027 | ₹ 7,930 | ₹ 8,076 |
| May 2027 | ₹ 7,982 | ₹ 8,048 |
| June 2027 | ₹ 8,031 | ₹ 8,168 |
| July 2027 | ₹ 8,176 | ₹ 8,262 |
| August 2027 | ₹ 8,214 | ₹ 8,264 |
| September 2027 | ₹ 8,201 | ₹ 8,335 |
| October 2027 | ₹ 8,330 | ₹ 8,370 |
| November 2027 | ₹ 8,340 | ₹ 8,378 |
| December 2027 | ₹ 8,320 | ₹ 8,354 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2027 is estimated to be ₹7949.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹8168.
● However, by the end of 2027, the price target is expected to reach ₹8354 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2028
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2028 | ₹ 8,329 | ₹ 8,376 |
| February 2028 | ₹ 8,325 | ₹ 8,353 |
| March 2028 | ₹ 8,296 | ₹ 8,354 |
| April 2028 | ₹ 8,379 | ₹ 8,506 |
| May 2028 | ₹ 8,407 | ₹ 8,482 |
| June 2028 | ₹ 8,456 | ₹ 8,600 |
| July 2028 | ₹ 8,633 | ₹ 8,687 |
| August 2028 | ₹ 8,634 | ₹ 8,693 |
| September 2028 | ₹ 8,630 | ₹ 8,760 |
| October 2028 | ₹ 8,759 | ₹ 8,805 |
| November 2028 | ₹ 8,768 | ₹ 8,800 |
| December 2028 | ₹ 8,747 | ₹ 8,783 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2028 is estimated to be ₹8376.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹8600.
● However, by the end of 2028, the price target is expected to reach ₹8783 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2029
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2029 | ₹ 8,755 | ₹ 8,803 |
| February 2029 | ₹ 8,752 | ₹ 8,781 |
| March 2029 | ₹ 8,723 | ₹ 8,774 |
| April 2029 | ₹ 8,798 | ₹ 8,934 |
| May 2029 | ₹ 8,834 | ₹ 8,915 |
| June 2029 | ₹ 8,881 | ₹ 9,015 |
| July 2029 | ₹ 9,049 | ₹ 9,117 |
| August 2029 | ₹ 9,086 | ₹ 9,120 |
| September 2029 | ₹ 9,121 | ₹ 9,390 |
| October 2029 | ₹ 9,194 | ₹ 9,477 |
| November 2029 | ₹ 9,277 | ₹ 9,567 |
| December 2029 | ₹ 9,379 | ₹ 9,682 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2029 is estimated to be ₹8803.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹9015.
● However, by the end of 2029, the price target is expected to reach ₹9682 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2030
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2030 | ₹ 9,491 | ₹ 9,808 |
| February 2030 | ₹ 9,491 | ₹ 9,808 |
| March 2030 | ₹ 9,510 | ₹ 9,832 |
| April 2030 | ₹ 9,548 | ₹ 9,881 |
| May 2030 | ₹ 9,606 | ₹ 9,951 |
| June 2030 | ₹ 9,682 | ₹ 10,031 |
| July 2030 | ₹ 9,692 | ₹ 10,051 |
| August 2030 | ₹ 9,760 | ₹ 10,172 |
| September 2030 | ₹ 9,858 | ₹ 10,289 |
| October 2030 | ₹ 10,020 | ₹ 10,428 |
| November 2030 | ₹ 10,095 | ₹ 10,490 |
| December 2030 | ₹ 10,297 | ₹ 10,711 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2030 is estimated to be ₹9808.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹10031.
● However, by the end of 2030, the price target is expected to reach ₹10711 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2040
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2040 | ₹ 26,012 | ₹ 28,420 |
| February 2040 | ₹ 26,012 | ₹ 28,420 |
| March 2040 | ₹ 26,064 | ₹ 28,492 |
| April 2040 | ₹ 26,168 | ₹ 28,634 |
| May 2040 | ₹ 26,325 | ₹ 28,834 |
| June 2040 | ₹ 26,536 | ₹ 29,068 |
| July 2040 | ₹ 26,562 | ₹ 29,126 |
| August 2040 | ₹ 26,748 | ₹ 29,476 |
| September 2040 | ₹ 27,016 | ₹ 29,815 |
| October 2040 | ₹ 27,461 | ₹ 30,217 |
| November 2040 | ₹ 27,667 | ₹ 30,398 |
| December 2040 | ₹ 28,221 | ₹ 31,037 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2040 is estimated to be ₹28420.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹29068.
● However, by the end of 2040, the price target is expected to reach ₹31037 considering bullish market trends.
Dr. Reddy’s Laboratories Share Price Target 2050
| Months | Minimum Price | Maximum Price |
|---|---|---|
| January 2050 | ₹ 71,288 | ₹ 82,356 |
| February 2050 | ₹ 71,288 | ₹ 82,356 |
| March 2050 | ₹ 71,431 | ₹ 82,561 |
| April 2050 | ₹ 71,717 | ₹ 82,974 |
| May 2050 | ₹ 72,147 | ₹ 83,555 |
| June 2050 | ₹ 72,724 | ₹ 84,232 |
| July 2050 | ₹ 72,797 | ₹ 84,400 |
| August 2050 | ₹ 73,306 | ₹ 85,413 |
| September 2050 | ₹ 74,040 | ₹ 86,395 |
| October 2050 | ₹ 75,261 | ₹ 87,562 |
| November 2050 | ₹ 75,826 | ₹ 88,087 |
| December 2050 | ₹ 77,342 | ₹ 89,937 |
● The initial price target for Dr. Reddy’s Laboratories Limited in 2050 is estimated to be ₹82356.
● With favorable market conditions, the mid-year price target for Dr. Reddy’s Laboratories Ltd. could reach ₹84232.
● However, by the end of 2050, the price target is expected to reach ₹89937 considering bullish market trends.
Dr. Reddy’s Laboratories Ltd. Chart Online
LIC India Share Price Target: Long-term Forecast & Analysis
LIC stands for Life Insurance Corporation of India. It started its operations as a corporate firm after the LIC Act came into effect in July 1956. READ MORE
Recommendations: Should I invest in Dr. Reddy’s Laboratories Ltd. stock or sell it?
The pharmaceutical markets are expected to raise with the compound annual growth rate (CAGR) ranging between 5% and 8% within the next five years. Some of these markets are believed to record growth of the range of high single digit to low double digits. With a tremendously growing pharmaceutical industry, India is poised to remain the powerhouse for supplying even high-quality generic medicines to developed nations. According to industry estimates, the domestic pharmaceutical market in India is expected to grow at 9-11% CAGR over the next 5 years boosted by growth in health consciousness, development of health care infrastructure and government policies favoring the sector.
As will be seen while making the conclusion, based on historical performance, Dr. Reddy’s Laboratories Ltd. has always posted good figures to its investors. One of the successes has been the company’s well-diversified product portfolio that operates both in the domestic and international market. Dr. Reddy’s currently operates in locations such as the United States, Europe and the emerging markets which are well-diversified sources of revenue for the company making it financially sound. This quite a broad presence in the international markets coupled with the vigorous accents on the research activities contributes to the company’s capability to reap synergistic benefits of future growth in these areas.
Based on these factors, it can be said that in the future Dr. Reddy’s Laboratories Ltd. will also show good result in terms of returns to its investors. Monitoring growth potential, company’s strategic plans aimed at diversification of the product range, geographical market penetration and improvement of production processes should contribute to achieving steady growth in the future. Thus, buying the financial instrument of Dr. Reddy’s Laboratories Ltd. may be considered as a profitable investment for those who are interested in investing in pharmaceutical industry in India and/or in the other countries.
Frequently Asked Questions (FAQ’s)
What is the Dr. Reddy’s Laboratories share price target for 2025?
As per our stock forecast, Dr. Reddy’s Laboratories share price target can be up to ₹7520 in 2025.
What is Dr. Reddy’s Laboratories stock projected to be worth in 5 years?
Our estimates show that Dr. Reddy’s Laboratories stock price could reach ₹9682 in the next 5 years.
What is the Dr. Reddy’s Laboratories share price target for 2030?
As per our stock forecast, Dr. Reddy’s Laboratories share price target can be up to ₹10711 in 2030.
What is Dr. Reddy’s Laboratories stock projected to be worth in 10 years?
Our estimates show that Dr. Reddy’s Laboratories stock price could reach ₹16696 in the next 10 years.
What is the Dr. Reddy’s Laboratories share price target for 2035?
As per our stock forecast, Dr. Reddy’s Laboratories share price target can be up to ₹18570 in 2035.
What is the Dr. Reddy’s Laboratories share price target for 2040?
As per our stock forecast, Dr. Reddy’s Laboratories share price target can be up to ₹31037 in 2040.
What is the Dr. Reddy’s Laboratories share price target for 2050?
As per our stock forecast, Dr. Reddy’s Laboratories share price target can be up to ₹89937 in 2050.
Price Prediction Methodology
The following tools are utilized for making predictions:
- Consensus and Expert Opinion: Forecasts are also informed by the consensus of expert opinions, providing a well-rounded perspective.
- Technical Analysis: This fundamental tool involves studying price charts and employing various indicators to forecast future price movements. The analysis is primarily conducted on medium- and long-term time frames for enhanced accuracy.
- Statistical Methods: These are used to evaluate the likelihood, type, and intensity of fundamental factors that could influence price fluctuations.
- Predictive Modeling: This approach leverages statistical algorithms to forecast future prices based on historical data patterns.
